Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0017168 (gastroesophageal reflux disease)
 11,783 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The factors predisposing to the development of Barrett's esophagus in patients with gastroesophageal reflux disease are unclear. We compared symptoms, esophageal acid and alkaline exposure (pH < 2, < 3, < 4, and > 7), lower esophageal sphincter resistance, esophageal clearance function, the gastric secretory state, gastric emptying, and duodenogastric reflux in 15 patients with Barrett's esophagus with 24 patients with esophagitis and with 22 normal subjects. Compared with patients with esophagitis, patients with Barrett's esophagus had less heartburn and regurgitation but had an increased frequency and duration of reflux episodes and percent time pH less than 2, less than 3, less than 4, and pH greater than 7 on ambulatory 24-hour esophageal pH monitoring. This was associated with a decreased lower esophageal sphincter resistance, a decreased contraction amplitude in the distal area of the esophagus, an increased frequency of nonperistaltic contractions and contractions less than 30 mm Hg on 24-hour ambulatory esophageal motility monitoring, increased basal and stimulated gastric acid secretion, and a higher prevalence of excessive duodenogastric reflux. These data show that despite less symptoms patients with Barrett's esophagus have a markedly increased esophageal acid and alkaline exposure compared with patients with esophagitis. This appears to be because of persistent reflux of highly concentrated gastric acid and duodenal contents across a mechanically defective lower esophageal sphincter in combination with inefficient esophageal clearance function.
J Thorac Cardiovasc Surg 1993 Jan
PMID:Functional foregut abnormalities in Barrett's esophagus. 841 90

Between January 1, 1980, and December 31, 1990, 147 patients (93 female and 54 male) were found to have an intrathoracic stomach. Median age was 69 years (range 34 to 89). Signs and symptoms occurred in 140 patients (95.2%) and were primarily obstructive. They included postprandial pain in 87 (59.2%), vomiting in 46 (31.3%), and dysphagia in 44 (29.9%); only 23 patients (15.7%) had symptoms of gastroesophageal reflux. Anemia was present in 31 patients (21.1%) and melena in 3. Elective repair was done in 119 patients and included an uncut Collis-Nissen repair in 81 patients (68.1%), a Belsey Mark IV repair in 19 (16.0%), a Nissen repair in 17 (14.3%), and a Harrington (anatomic) repair in 2 (1.7%). Thirty-two patients had complications (26.9%). There were no operative deaths. Median follow-up was 42 months. Results were excellent in 69 patients (60.0%), good in 38 (33.0%), fair in 6 (5.2%), and poor in 2 (1.7%). Five patients had emergency operations for suspected strangulation; three had gastric necrosis, and one died. Two of the four operative survivors had excellent results. Twenty-three other patients were followed up with medical management for a median of 78 months (range 12 to 268 months). In four patients progressive symptoms developed, and one patient died from aspiration. We conclude that patients with an intrathoracic upside-down stomach who have obstructive symptoms at initial presentation should undergo repair and that elective operation is safe and effective. Gastric strangulation, however, is rare.
J Thorac Cardiovasc Surg 1993 Feb
PMID:Intrathoracic stomach. Presentation and results of operation. 842 52

Transhiatal esophagectomy has been performed in 583 patients with diseases of the intrathoracic esophagus: 166 (28%) benign and 417 (72%) malignant (6% upper, 28% middle, and 66% lower third and cardia). The benign esophageal diseases included strictures (40%); neuromotor dysfunction-achalasia (24%), esophageal spasm (8%); recurrent gastroesophageal reflux (16%); acute perforation (5%); acute caustic injury (2%); and others (3%). Among the patients with benign disease, 60% had undergone at least one prior esophageal operation. Transhiatal esophagectomy was possible in 97% of patients in whom it was attempted, 19 patients (13 with benign disease and 6 with carcinoma) requiring addition of a thoracotomy for esophageal resection. Esophageal resection and reconstruction were performed in a single operation in all but 5 patients. The esophageal substitute was positioned in the posterior mediastinum in the original esophageal bed in 96%. Stomach was used to replace the esophagus in 553 patients (95%) and colon in 28 (5%) who had undergone prior gastric resections. Overall hospital mortality was 5% in patients with benign disease and 5% in those with carcinoma. There was 1 intraoperative death caused by uncontrollable hemorrhage. Complications included intraoperative entry into a pleural cavity necessitating a chest tube (74%), anastomotic leak (9%), recurrent laryngeal nerve paralysis (3%), and chylothorax and tracheal laceration (< 1% each). Three patients required reoperation for mediastinal bleeding. Average intraoperative blood loss was 875 ml (1023 ml for benign disease and 817 ml for carcinoma). Of the surviving patients, 88% were discharged able to swallow within 3 weeks of operation and 78% within 2 weeks. The actuarial survival of the patients with carcinoma is similar to that reported after more traditional transthoracic esophagectomy. Among patients with benign disease, good or excellent functional results have been achieved in nearly 70% after a cervical esophagogastric anastomosis. Although approximately 44% have required one or more anastomotic dilations within 1 to 3 months of operation, true anastomotic strictures have developed in 10%. Clinically troublesome nocturnal reflux has occurred in 3%. Transhiatal esophagectomy is feasible in most patients requiring esophageal resection for either benign or malignant disease and is a safe, well-tolerated operation if performed with care and for the proper indications.
J Thorac Cardiovasc Surg 1993 Feb
PMID:Transhiatal esophagectomy for benign and malignant disease. 842 54

The role of an antireflux procedure as an adjunct to esophagomyotomy for achalasia remains a subject of controversy. Little objective documentation exists of this operation's effect on sphincteric competence and the degree of postoperative gastroesophageal reflux. This report of esophageal manometry and 24-hour pH monitoring on 14 patients with esophageal achalasia whom we had previously treated by a short esophagomyotomy without an antireflux procedure provides such documentation. Esophagomyotomy reduced lower esophageal sphincter pressure by 12% to 71% (mean 41%) from a preoperative mean of 26.7 mm Hg to a postoperative mean of 14.6 mm Hg. The number of postoperative episodes of acid reflux per patient in 24 hours was fewer than 29 (normal < 49) in 13 patients, with a median of 12 episodes for the entire group. Esophageal acid exposure, measured as percentage of total time with pH less than 4.0 (normal < 4.5%), was below 4.5% in 10 patients, six of whom had values less than 1%. Among the four patients with values greater than 4.5%, only one had a temporal correlation of symptoms with an episode of acid reflux. Multivariate analysis showed that esophageal acid exposure time correlated only with the level of residual lower esophageal sphincter pressure during the relaxation phase of deglutition. A pressure less than 8 mm Hg was predictive of normal acid contact time (p < 0.001). Mean lower esophageal sphincter pressure, percent reduction in lower esophageal sphincter amplitude, postoperative vector volume, and length of the lower esophageal sphincter did not significantly correlate with amount of esophageal acid exposure. We conclude that a short esophagomyotomy without an antireflux procedure results in a competent lower esophageal sphincter in most patients. Increased esophageal acid exposure, when it occurs, is due to slow clearance of esophageal acid from relatively few reflux episodes and is more likely to occur when there is a high residual pressure during deglutition after myotomy. These findings suggest that the addition of an antireflux procedure to a short esophagomyotomy would not be expected to improve clinical results.
J Thorac Cardiovasc Surg 1996 Jan
PMID:Objective assessment of gastroesophageal reflux after short esophagomyotomy for achalasia with the use of manometry and pH monitoring. 855 54

Barrett's esophagus, a premalignant condition associated with chronic gastroesophageal reflux, carries an approximate 40-fold increase in the incidence of adenocarcinoma. Between 1975 and 1994, 113 patients with Barrett's esophagus underwent antireflux procedures at the Mayo Clinic. The antireflux procedure was performed more than 3 months after the diagnosis of Barrett's disease in 39 patients (34.5%) and during the initial preoperative evaluation in 74 (65.5%). Uncut Collis-Nissen fundoplication was performed in 69 patients (61.1%), Nissen fundoplication was performed in 16 (14.2%), cut Collis-Nissen fundoplication was performed in 12 (10.6%), Belsey repair was performed in nine (8.0%), Collis-Belsey repair was performed in six (5.3%), and Nissen fundoplication with an anterior gastropexy was performed in one (0.9%). There was one operative death (0.9% mortality). Morbidity occurred in 41 patients (36.3%), including cardiac arrhythmia in eight (7.0%), pneumonia in six (5.3%), empyema in five (4.4%), hemorrhage in four (3.6%), myocardial infarction in two (1.8%), and wound dehiscence, wound infection, perforated duodenal ulcer, and postoperative leak in one each (0.9%). Median follow-up for the 112 survivors of operation was 6.5 years (range 4 months to 18.2 years). Excellent or good alleviation of symptoms was obtained in 92 patients (82.2%). Ninety-nine patients (88.4%) are currently alive and 13 (11.6%) have died. Three patients (2.7%) subsequently had adenocarcinoma of the esophagus after the antireflux procedure at 13, 25, and 39 months; two of these died of cancer. The incidence of esophageal carcinoma in this select group of patients was one in 273.8 patient-years of follow-up. We conclude that although antireflux procedures in patients with Barrett's esophagus result in long-term control of reflux symptoms, the possibility of esophageal cancer still exists. Endoscopic surveillance should therefore be recommended.
J Thorac Cardiovasc Surg 1996 Jun
PMID:Barretts's esophagus: does an antireflux procedure reduce the need for endoscopic surveillance? 864 13

From January 1960 to June 1995, 185 patients underwent reoperation without esophageal resection for symptoms of recurrent gastroesophageal reflux disease. There were 102 men and 83 women. Median age was 58 years (range 20 to 84 years). A single previous antireflux operation had been performed in 147 patients, two in 33, and three in 5. The median interval between the reoperation and the previous operation was 36 months (range 1 to 291 months). Indications for reoperation were symptoms in 184 patients and a large paraesophageal hernia in one patients. The surgical approach was by means of a thoracotomy in 133 patients (71.9%), laparotomy in 27 (14.6%), and a thoracoabdominal incision in 25 (13.5%). A Nissen fundoplication was performed in 107 patients (57.8%), Belsey fundoplication in 47 (25.4%), truncal vagotomy and antrectomy with Roux-en-Y reconstruction in 17 (9.2%), anatomic hernia repair in 12 (6.5%), and Hill gastropexy in 2 (1.1%). A Collis gastroplasty was added to the fundoplication in 116 patients (62.7%), and a pyloroplasty was performed in 17 (9.2%). There was one operative death (0.5%). Complications occurred in 47 patients (25.4%). Median postoperative hospitalization was 9 days (range 5 to 58 days). Follow-up was complete in 156 patients (84.3%) and ranged from 3 to 283 months (median 44 months). Improvement occurred in 137 patients (87.8%). Functional results were classified as excellent in 65 patients (41.6%), good in 29 (18.6%), fair in 43 (27.6%), and poor in 19 (12.2%). No single operative approach or procedure proved to be functionally superior. We conclude that reoperation with esophageal preservation after a failed antireflux procedure will result in significant functional benefit and can be performed with low mortality and acceptable morbidity. The type of repair should be tailored to the individual patient.
J Thorac Cardiovasc Surg 1997 Mar
PMID:Long-term results after reoperation for failed antireflux procedures. 908 Nov 1

The introduction of laparoscopic techniques for performing anti-reflux surgery has led to a significant increase in the number of such procedures being performed. Furthermore, the threshold of symptoms required for performance of such procedures seems to have been lowered. For these reasons, it is more important than ever to ensure that symptoms attributed to gastroesophageal reflux are appropriately evaluated for a high rate of clinical success after anti-reflux surgery. Clinical assessment requires a careful history, expert radiographic assessment, and endoscopy by an experienced observer. Objective measurements including esophageal manometry, acid perfusion studies, and 24-hour esophageal pH monitoring continue to play an important role in the diagnosis and management of associated functional disorders of the esophagus.
Semin Thorac Cardiovasc Surg 1997 Apr
PMID:Current role of esophageal function studies. 925 78

It is generally agreed that no single surgical technique of repair provides adequate results under all circumstances. It is equally important to recognize that almost all conditions which complicate hiatus hernia and gastroesophageal reflux are of a benign order, and the decision for surgery is an option for the adequately informed patient. This article presents the indications for operation and the criteria for selection of open repairs. It is not a review article, but rather expresses the experience and opinions of the author.
Semin Thorac Cardiovasc Surg 1997 Apr
PMID:Hiatus hernia and gastroesophageal reflux: indications for surgery and selection of operation. 925 79

Gastroesophageal reflux disease (GERD) is a common problem in medical practice. Estimates are that 10% of the U.S. population will experience daily heartburn and up to 40% will have symptomatic GERD on a frequent basis. Current medical therapy allows physicians to provide complete symptom relief, maintain long-term symptom remission and prevent complications. New advances in minimally invasive surgical techniques have made antireflux surgery an attractive alternate for long-term management in selected patients. This article reviews current medical treatment and indications for surgical referral in GERD.
Semin Thorac Cardiovasc Surg 1997 Apr
PMID:Current medical treatment and indications for surgical referral for gastroesophageal reflux disease (GERD). 925 80

Laparoscopic antireflux surgery is a safe and effective alternative surgical approach for the treatment of gastroesophageal reflux disease (GERD). However, the same rigorous evaluation required for open fundoplication is mandated for patients undergoing laparoscopic antireflux surgery. For successful laparoscopic antireflux surgery, both the mastery of laparoscopic techniques and the application of the principles of antireflux surgery are required. Operative mortality and morbidity compare favorably with those of open antireflux procedures, and there is a marked reduction of certain complications. Meticulous laparoscopic technique during the mobilization of the gastric cardia and esophagus will limit mortality and intraoperative and postoperative complications. Although laparoscopic antireflux surgery shortens postoperative recovery and speeds return to work, it may be the double-edged sword causing early failures. Short and intermediate term results compare similarly with open antireflux surgery. Laparoscopic antireflux surgery is an important and significant advancement in the evolution of GERD therapy, its definitive role in the surgeon's armamentarium is dependent on evaluation of long-term data.
Semin Thorac Cardiovasc Surg 1997 Apr
PMID:Laparoscopic antireflux surgery. 925 81


<< Previous 1 2 3 4 5 6 7 8 9 Next >>